Kasturi Sarkar, Parames C. Sil, Seyed Fazel Nabavi, Ioana Beridan Neagoe, Cosmin Andrei Cismaru, Seyed Mohammad Nabavi and Solomon Habtemariam* Pages 1 - 8 ( 8 )
The global spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes COVID19 has become a source of grave medical and socioeconomic concern to the human society. Since its first appearance in the Wuhan region of China in December 2019, the most effective measures of managing the spread of SARS-CoV-2 infection have been social distancing and lockdown of human activity; the level of which has not been seen in our generations. An effective control of the viral infection and COVID-19 will ultimately depend on the development of either a vaccine or therapeutic agents. This article highlights the progresses made so far in these strategies by assessing key targets associated with the viral replication cycle. The key viral proteins and enzymes that could be targeted by new and repurposed drugs are discussed.
COVID-19, SARS-CoV-2, infection cycle, structural proteins, non-structural proteins, RNA dependent RNA polymerase, proteases, helicase, nucleosides.
Department of Microbiology, St. Xavier’s College, Kolkata, Department of Molecular Medicine, Bose Institute, Kolkata, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, ChathamMaritime, Kent ME4 4TB